Stockscreener 앱 받기
10.99
6.39%
-0.75
전일 마감가:
$11.74
열려 있는:
$11
하루 거래량:
11,378
Relative Volume:
0.42
시가총액:
$35.72M
수익:
-
순이익/손실:
$-53.45M
주가수익비율:
-0.5062
EPS:
-21.71
순현금흐름:
$-31.81M
1주 성능:
-0.18%
1개월 성능:
+0.27%
6개월 성능:
-2.74%
1년 성능:
-3.00%
1일 변동 폭
$10.74
$11.56
1주일 범위
$10.74
$12.93
52주 변동 폭
$5.9999
$18.17
Surrozen Inc Stock (SRZN) Company Profile
명칭
Surrozen Inc
전화
650-475-2820
주소
171 OYSTER POINT BLVD, SOUTH SAN FRANCISCO
SRZN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SRZN
Surrozen Inc
|
10.99 | 35.72M | 0 | -53.45M | -31.81M | -21.71 |
|
VRTX
Vertex Pharmaceuticals Inc
|
474.62 | 121.88B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.45 | 62.69B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
555.11 | 33.86B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
235.74 | 30.51B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
238.51 | 25.69B | 3.81B | -644.79M | -669.77M | -6.24 |
Surrozen Inc Stock (SRZN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-01-30 | 개시 | H.C. Wainwright | Buy |
| 2025-01-03 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2021-10-11 | 개시 | BofA Securities | Buy |
| 2021-09-15 | 개시 | Guggenheim | Buy |
| 2021-09-07 | 개시 | Stifel | Buy |
Surrozen Inc 주식(SRZN)의 최신 뉴스
When (SRZN) Moves Investors should Listen - news.stocktradersdaily.com
Finance Watch: As Stocks Tumble, Offerings Slow, Financial Alternatives Rise - insights.citeline.com
Surrozen’s Strategic Shift to Ophthalmology and Wnt Pathway Innovations Justify Buy Rating - TipRanks
Surrozen (SRZN) to Release Earnings on Wednesday - Defense World
Surrozen Focuses on Ophthalmology Amid Financial Challenges - TipRanks
Surrozen Provides Fourth Quarter and Full Year 2024 Financial Results and Business Updates - The Manila Times
Surrozen Lands Massive $175M Deal: What This Means for Its Eye Disease Pipeline - Stock Titan
Surrozen sees $11.9 million in stock purchases by Column Group - Investing.com South Africa
Surrozen Secures $76.4M in Private Placement Deal - TipRanks
Surrozen drops hepatitis drug after Phase I flop - Yahoo
Surrozen shifts focus to eye disease treatments, secures $175M funding - Investing.com India
Surrozen Secures $175Mln In Oversubscribed Private Placement To Advance Ophthalmology Pipeline - Nasdaq
Surrozen to Raise Up to $175 Million in Private Placement; Fine-Tunes Ophthalmology Clinical Programs - MarketScreener
Surrozen raises $175M, to focus on ophthalmology; CBC Group has a new $1B fund - Endpoints News
Surrozen shifts focus to eye disease treatments, secures $175M funding By Investing.com - Investing.com South Africa
Surrozen, Inc. Prioritizes Ophthalmology Pipeline with $175 Million Financing and Discontinues SZN-043 Development - Nasdaq
Surrozen Announces an Oversubscribed $175 Million Private Placement of Securities to Focus on Selective Wnt Mimetic Therapeutics to Treat Serious Eye Diseases - The Manila Times
Major Pivot: Surrozen Lands $175M to Develop Breakthrough Eye Disease Treatments - Stock Titan
(SRZN) Trading Advice - Stock Traders Daily
Reviewing Surrozen (NASDAQ:SRZN) & Tenaya Therapeutics (NASDAQ:TNYA) - Defense World
Wnt efforts condensing at Dewpoint, Surrozen, more - BioWorld MedTech
(SRZN) On The My Stocks Page - Stock Traders Daily
Week Ahead (Sep.13- 17): FDA Decision, Data Readouts (CALT, ASLN, LIFE…) - RTTNews
Better Warren Buffett Stock: Nu Holdings vs. Bank of America - The Globe and Mail
(SRZN) Trading Signals - Stock Traders Daily
H.C. Wainwright sets $32 target on Surrozen stock with Buy rating - MSN
How To Trade (SRZN) - Stock Traders Daily
Nektar Therapeutics (NKTR) Stock Drops Amid Biotech Sector Volat - GuruFocus.com
HC Wainwright Predicts Surrozen FY2024 Earnings - Defense World
Surrozen (NASDAQ:SRZN) Research Coverage Started at HC Wainwright - Defense World
HC Wainwright & Co. Initiates Coverage of Surrozen (SRZN) with Buy Recommendation - MSN
This Worthington Enterprises Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday - Benzinga
HC Wainwright Initiates Coverage on Surrozen With Buy Rating, $32 Price Target -January 30, 2025 at 08:15 am EST - Marketscreener.com
REGENTS OF THE UNIVERSITY OF CALIFORNIA Acquires Significant Sta - GuruFocus.com
REGENTS OF THE UNIVERSITY OF CALIFORNIA Acquires Shares in Surro - GuruFocus.com
Here's Why We're A Bit Worried About Surrozen's (NASDAQ:SRZN) Cash Burn Situation - Yahoo Finance
(SRZN) Trading Report - Stock Traders Daily
12 Health Care Stocks Moving In Thursday's Pre-Market SessionAditxt (NASDAQ:ADTX), Aclarion (NASDAQ:ACON) - Benzinga
Financial Analysis: Recursion Pharmaceuticals (NASDAQ:RXRX) versus Surrozen (NASDAQ:SRZN) - Defense World
Surrozen exec vice president sells $14,642 in stock - Investing.com
Surrozen exec vice president sells $14,642 in stock By Investing.com - Investing.com UK
Surrozen's CFO and COO sells $20,513 in stock - Investing.com
Surrozen's CFO and COO sells $20,513 in stock By Investing.com - Investing.com UK
Surrozen (NASDAQ:SRZN) Upgraded by Guggenheim to “Buy” Rating - Defense World
Surrozen stock soars to 52-week high, hits $16.35 - Investing.com
Block upgraded, Bumble downgraded: Wall Street's top analyst calls - Yahoo Finance
(SRZN) Investment Analysis and Advice - Stock Traders Daily
Financial Review: Surrozen (NASDAQ:SRZN) & Vericel (NASDAQ:VCEL) - Defense World
Learn to Evaluate (SRZN) using the Charts - Stock Traders Daily
When the Price of (SRZN) Talks, People Listen - Stock Traders Daily
Companies Like Surrozen (NASDAQ:SRZN) Could Be Quite Risky - Simply Wall St
Surrozen Inc (SRZN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
3.01%
자본화:
|
볼륨(24시간):